Cargando…

Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria

INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeyemi, Olusegun Adewale, Itanyi, Ijeoma Uchenna, Ozigbu, Chamberline Ekene, Stadnick, Nicole, Tsuyuki, Kiyomi, Olayiwola, Olanrewaju, Ogidi, Amaka Grace, Eze, Chuka, Aarons, Gregory Alan, Onoka, Chima Ariel, Ezeanolue, Echezona Edozie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498243/
https://www.ncbi.nlm.nih.gov/pubmed/32941424
http://dx.doi.org/10.1371/journal.pone.0236456
_version_ 1783583468239716352
author Adeyemi, Olusegun Adewale
Itanyi, Ijeoma Uchenna
Ozigbu, Chamberline Ekene
Stadnick, Nicole
Tsuyuki, Kiyomi
Olayiwola, Olanrewaju
Ogidi, Amaka Grace
Eze, Chuka
Aarons, Gregory Alan
Onoka, Chima Ariel
Ezeanolue, Echezona Edozie
author_facet Adeyemi, Olusegun Adewale
Itanyi, Ijeoma Uchenna
Ozigbu, Chamberline Ekene
Stadnick, Nicole
Tsuyuki, Kiyomi
Olayiwola, Olanrewaju
Ogidi, Amaka Grace
Eze, Chuka
Aarons, Gregory Alan
Onoka, Chima Ariel
Ezeanolue, Echezona Edozie
author_sort Adeyemi, Olusegun Adewale
collection PubMed
description INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can transmit both viruses vertically as well as horizontally to their children. The objectives of this study were to investigate the prevalence and determinants of HBV among women of reproductive age living with HIV. METHODS: This was a cross-sectional study of HIV-infected women of reproductive age in Benue State, Nigeria. Participants were eligible for the study if they were HIV-infected women (ages 18–45 years) receiving care from any of the selected study sites. A global rapid hepatitis B surface antigen (HBsAg) antibody test strip was used to test for HBsAg in plasma. A pretested questionnaire was used to collect data on sociodemographic, clinical and lifestyle characteristics of participants. We estimated prevalence of HBV infection and used multivariable logistic regression to determine factors associated with the infection at a significance level of <0.05. RESULTS: A total of 6577 women were screened for HBsAg. The prevalence of HBV was 10.3% (95% CI: 9.5–10.9%). Age, parity and male partner’s HIV status were found to be associated with having HBV infection. Compared to women older than 40 years, the odds of HBV infection increased significantly with increasing age until age 35 years and decreased significantly with increasing parity (versus no parity). Women with HIV-infected partners and those without a partner had higher odds of HBV infection compared to women with HIV-negative partners. CONCLUSION: HBV is hyperendemic among HIV-infected women of reproductive age in North Central Nigeria. Specific programs targeting HBV testing, vaccination and treatment of all women of reproductive age need to be developed in this resource-limited, high-need setting.
format Online
Article
Text
id pubmed-7498243
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74982432020-09-24 Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria Adeyemi, Olusegun Adewale Itanyi, Ijeoma Uchenna Ozigbu, Chamberline Ekene Stadnick, Nicole Tsuyuki, Kiyomi Olayiwola, Olanrewaju Ogidi, Amaka Grace Eze, Chuka Aarons, Gregory Alan Onoka, Chima Ariel Ezeanolue, Echezona Edozie PLoS One Research Article INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can transmit both viruses vertically as well as horizontally to their children. The objectives of this study were to investigate the prevalence and determinants of HBV among women of reproductive age living with HIV. METHODS: This was a cross-sectional study of HIV-infected women of reproductive age in Benue State, Nigeria. Participants were eligible for the study if they were HIV-infected women (ages 18–45 years) receiving care from any of the selected study sites. A global rapid hepatitis B surface antigen (HBsAg) antibody test strip was used to test for HBsAg in plasma. A pretested questionnaire was used to collect data on sociodemographic, clinical and lifestyle characteristics of participants. We estimated prevalence of HBV infection and used multivariable logistic regression to determine factors associated with the infection at a significance level of <0.05. RESULTS: A total of 6577 women were screened for HBsAg. The prevalence of HBV was 10.3% (95% CI: 9.5–10.9%). Age, parity and male partner’s HIV status were found to be associated with having HBV infection. Compared to women older than 40 years, the odds of HBV infection increased significantly with increasing age until age 35 years and decreased significantly with increasing parity (versus no parity). Women with HIV-infected partners and those without a partner had higher odds of HBV infection compared to women with HIV-negative partners. CONCLUSION: HBV is hyperendemic among HIV-infected women of reproductive age in North Central Nigeria. Specific programs targeting HBV testing, vaccination and treatment of all women of reproductive age need to be developed in this resource-limited, high-need setting. Public Library of Science 2020-09-17 /pmc/articles/PMC7498243/ /pubmed/32941424 http://dx.doi.org/10.1371/journal.pone.0236456 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Adeyemi, Olusegun Adewale
Itanyi, Ijeoma Uchenna
Ozigbu, Chamberline Ekene
Stadnick, Nicole
Tsuyuki, Kiyomi
Olayiwola, Olanrewaju
Ogidi, Amaka Grace
Eze, Chuka
Aarons, Gregory Alan
Onoka, Chima Ariel
Ezeanolue, Echezona Edozie
Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title_full Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title_fullStr Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title_full_unstemmed Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title_short Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
title_sort sero-prevalence and determinants of hepatitis b among a cohort of hiv-infected women of reproductive age in nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498243/
https://www.ncbi.nlm.nih.gov/pubmed/32941424
http://dx.doi.org/10.1371/journal.pone.0236456
work_keys_str_mv AT adeyemiolusegunadewale seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT itanyiijeomauchenna seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT ozigbuchamberlineekene seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT stadnicknicole seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT tsuyukikiyomi seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT olayiwolaolanrewaju seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT ogidiamakagrace seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT ezechuka seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT aaronsgregoryalan seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT onokachimaariel seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria
AT ezeanolueechezonaedozie seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria